The Globe and Mail reports in its Friday, Sept. 15, edition that Raymond James analyst Brian MacArthur is sticking with his "outperform" call on Cameco. The Globe's David Leeder writes in the Eye On Equities column that Mr. MacArthur raised his share target by $4 to $56. Analysts on average target the shares at $53.89. The Globe says Mr. MacArthur boosted his share target to account for the increase in the price of uranium. As well, he sees a "positive" demand outlook for the commodity. Mr. MacArthur says in a note: "We believe Cameco provides investors with lower-risk exposure to the uranium market given its diversification of uranium sources. These sources are supported by a portfolio of long-term contracts that provide some downside protection in periods of depressed spot uranium prices, while maintaining optionality to higher uranium prices. In addition, the company has multiple operations curtailed that can be brought back should uranium prices increase. Although the 2021 tax court decision applies only to the 2003, 2005, and 2006 tax years, we view it as a positive for Cameco given we believe it will be relevant in determining the outcome for other years and reduces risk related to the CRA dispute."